| Stage | PTGX | % of rev | LLY | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $213M | 100.00% | $24.4B | 100.00% | LLY ×114.29 |
| Gross profit | $213M | 100.00% | $20.5B | 83.88% | PTGX +16.1pp |
| Operating income | $159M | 74.37% | $8.6B | 35.28% | PTGX +39.1pp |
| Pre-tax income | $165M | 77.35% | $8.4B | 34.46% | PTGX +42.9pp |
| Net income | $163M | 76.28% | $6.5B | 26.44% | PTGX +49.8pp |
| Stage | PTGX | LLY | Gap · A − B |
|---|---|---|---|
| Revenue | $213M100.00% | $24.4B100.00% | LLY ×114.29 |
| Gross profit | 100.00%$213M | 83.88%$20.5B | PTGX +16.1pp |
| Operating income | 74.37%$159M | 35.28%$8.6B | PTGX +39.1pp |
| Pre-tax income | 77.35%$165M | 34.46%$8.4B | PTGX +42.9pp |
| Net income |
| 76.28%$163M |
| 26.44%$6.5B |
| PTGX +49.8pp |
No shared counterparties.